Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity

Clinical trial NCT03313752 · COMPLETED

Trial details

NCT number: NCT03313752
Sponsor: Giaccari Andrea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus Stable Coronary Artery Disease

Start date: 2017-12-01
Primary completion: 2022-10-06
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.